Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Oxygen-Sensing Difluoroboron Thienyl Phenyl β-Diketonate Polylactides.

DeRosa CA, Kolpaczynska M, Kerr C, Daly ML, Morris WA, Fraser CL.

Chempluschem. 2017 Mar;82(3):399-406. doi: 10.1002/cplu.201600520. Epub 2016 Dec 8.

PMID:
31962036
2.

Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing.

Sun N, Ning B, Hansson KM, Bruce AC, Seaman SA, Zhang C, Rikard M, DeRosa CA, Fraser CL, Wågberg M, Fritsche-Danielson R, Wikström J, Chien KR, Lundahl A, Hölttä M, Carlsson LG, Peirce SM, Hu S.

Sci Rep. 2018 Nov 30;8(1):17509. doi: 10.1038/s41598-018-35570-6.

3.

Multi-stimuli responsive luminescent azepane-substituted β-diketones and difluoroboron complexes.

Wang F, DeRosa CA, Daly ML, Song D, Fraser CL.

Mater Chem Front. 2017 Sep 1;1(9):1866-1874. doi: 10.1039/C7QM00137A. Epub 2017 May 25.

4.

Phosphorescence Tuning through Heavy Atom Placement in Unsymmetrical Difluoroboron β-Diketonate Materials.

Liu T, Zhang G, Evans RE, Trindle CO, Altun Z, DeRosa CA, Wang F, Zhuang M, Fraser CL.

Chemistry. 2018 Feb 6;24(8):1859-1869. doi: 10.1002/chem.201703513. Epub 2018 Jan 4.

PMID:
29121425
5.

Meta-Alkoxy-Substituted Difluoroboron Dibenzoylmethane Complexes as Environment-Sensitive Materials.

Daly ML, Kerr C, DeRosa CA, Fraser CL.

ACS Appl Mater Interfaces. 2017 Sep 20;9(37):32008-32017. doi: 10.1021/acsami.7b06910. Epub 2017 Sep 6.

PMID:
28876889
6.

Luminescent Difluoroboron β-Diketonate PLA-PEG Nanoparticle.

Kerr C, DeRosa CA, Daly ML, Zhang H, Palmer GM, Fraser CL.

Biomacromolecules. 2017 Feb 13;18(2):551-561. doi: 10.1021/acs.biomac.6b01708. Epub 2017 Feb 2.

7.

Oxygen Sensing Difluoroboron β-Diketonate Polylactide Materials with Tunable Dynamic Ranges for Wound Imaging.

DeRosa CA, Seaman SA, Mathew AS, Gorick CM, Fan Z, Demas JN, Peirce SM, Fraser CL.

ACS Sens. 2016 Nov 23;1(11):1366-1373. doi: 10.1021/acssensors.6b00533. Epub 2016 Nov 14.

8.
9.

Thienyl Difluoroboron β-Diketonates in Solution and Polylactide Media.

Kolpaczynska M, DeRosa CA, Morris WA, Fraser CL.

Aust J Chem. 2016;69(5):537-545. Epub 2016 Mar 7.

10.

Blue Thermally Activated Delayed Fluorescence from a Biphenyl Difluoroboron β-Diketonate.

Daly ML, DeRosa CA, Kerr C, Morris WA, Fraser CL.

RSC Adv. 2016;6(85):81631-81635. doi: 10.1039/c6ra18374c. Epub 2016 Aug 30.

11.

Tailoring Oxygen Sensitivity with Halide Substitution in Difluoroboron Dibenzoylmethane Polylactide Materials.

DeRosa CA, Kerr C, Fan Z, Kolpaczynska M, Mathew AS, Evans RE, Zhang G, Fraser CL.

ACS Appl Mater Interfaces. 2015 Oct 28;7(42):23633-43. doi: 10.1021/acsami.5b07126. Epub 2015 Oct 19.

12.

Oxygen Sensing Difluoroboron Dinaphthoylmethane Polylactide.

DeRosa CA, Samonina-Kosicka J, Fan Z, Hendargo HC, Weitzel DH, Palmer GM, Fraser CL.

Macromolecules. 2015 May 12;48(9):2967-2977.

13.

Dual-Emissive Difluoroboron Naphthyl-Phenyl β-Diketonate Polylactide Materials: Effects of Heavy Atom Placement and Polymer Molecular Weight.

Samonina-Kosicka J, DeRosa CA, Morris WA, Fan Z, Fraser CL.

Macromolecules. 2014 Jun 10;47(11):3736-3746. Epub 2014 May 23.

14.

Association between home availability and vegetable consumption in youth: a review.

Cook LT, O'Reilly GA, DeRosa CJ, Rohrbach LA, Spruijt-Metz D.

Public Health Nutr. 2015 Mar;18(4):640-8. doi: 10.1017/S1368980014000664. Epub 2014 May 1. Review.

PMID:
24785645
15.

Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progression.

Derosa CA, Furusato B, Shaheduzzaman S, Srikantan V, Wang Z, Chen Y, Seifert M, Ravindranath L, Young D, Nau M, Dobi A, Werner T, McLeod DG, Vahey MT, Sesterhenn IA, Srivastava S, Petrovics G.

Prostate Cancer Prostatic Dis. 2012 Jun;15(2):150-6. doi: 10.1038/pcan.2011.61. Epub 2011 Nov 29. Erratum in: Prostate Cancer Prostatic Dis. 2012 Jun;15(2):210. Siefert, M [corrected to Seifert, M].

PMID:
22343836
16.

School-based health center access, reproductive health care, and contraceptive use among sexually experienced high school students.

Ethier KA, Dittus PJ, DeRosa CJ, Chung EQ, Martinez E, Kerndt PR.

J Adolesc Health. 2011 Jun;48(6):562-5. doi: 10.1016/j.jadohealth.2011.01.018.

PMID:
21575814
17.

Moving past sleight of hand.

Mintken PE, Derosa C, Little T, Smith B.

J Orthop Sports Phys Ther. 2010 May;40(5):253-5. doi: 10.2519/jospt.2010.0105.

PMID:
20436243
18.

Serum parathyroid hormone and phosphate influence the levels of circulating CD34+ cells in uremia.

Lomonte C, Derosa C, Vernaglione L, Casucci F, Losurdo N, Libutti P, Teutonico A, Basile C.

J Nephrol. 2010 Nov-Dec;23(6):693-8.

PMID:
20301083
19.

A model for standardizing manipulation terminology in physical therapy practice.

Mintken PE, Derosa C, Little T, Smith B; American Academy of Orthopaedic Manual Physical Therapists.

J Man Manip Ther. 2008;16(1):50-6. No abstract available.

20.

Peritoneal mesothelioma.

Hesdorffer ME, Chabot J, DeRosa C, Taub R.

Curr Treat Options Oncol. 2008 Jun;9(2-3):180-90. doi: 10.1007/s11864-008-0072-2. Epub 2008 Oct 8. Review.

PMID:
18841478
21.

AAOMPT clinical guidelines: A model for standardizing manipulation terminology in physical therapy practice.

Mintken PE, DeRosa C, Little T, Smith B; American Academy of Orthopaedic Manual Physical Therapists.

J Orthop Sports Phys Ther. 2008 Mar;38(3):A1-6. doi: 10.2519/jospt.2008.0301. Epub 2008 Feb 29.

PMID:
18349498
22.
23.

Relationship between number of allergic sensitizations and immunity impairment: anything new in immunotherapy for allergies and vaccines planning?

Manfredi G, Lucarelli G, Derosa C, Ventura E.

Eur Ann Allergy Clin Immunol. 2005 Oct;37(8):321-4.

PMID:
17066651
24.

A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.

Haddad RI, Weinstein LJ, Wieczorek TJ, Bhattacharya N, Raftopoulos H, Oster MW, Zhang X, Latham VM Jr, Costello R, Faucher J, DeRosa C, Yule M, Miller LP, Loda M, Posner MR, Shapiro GI.

Clin Cancer Res. 2004 Jul 15;10(14):4680-7.

25.

Pregnancy in renal transplantation: immunologic evaluation of neonates from mothers with transplanted kidney.

Schen FP, Stallone G, Schena A, Manfredi G, Derosa C, Procino A, Di Paolo S.

Transpl Immunol. 2002 May;9(2-4):161-4. Review.

PMID:
12180825
26.
27.

Radio frequency transmyocardial revascularization enhances angiogenesis and causes myocardial denervation in canine model.

Yamamoto N, Gu A, DeRosa CM, Shimizu J, Zwas DR, Smith CR, Burkhoff D.

Lasers Surg Med. 2000;27(1):18-28.

PMID:
10918289
28.

Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels.

Di Paolo S, Schena A, Morrone LF, Manfredi G, Stallone G, Derosa C, Procino A, Schena FP.

Transplantation. 2000 May 27;69(10):2049-54.

PMID:
10852595
29.

Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization.

Yamamoto N, Kohmoto T, Roethy W, Gu A, DeRosa C, Rabbani LE, Smith CR, Burkhoff D.

Basic Res Cardiol. 2000 Feb;95(1):55-63.

PMID:
10752546
30.

Liver metastases are enhanced in homozygous deletionally mutant ICAM-1 or LFA-1 mice.

Marvin MR, Southall JC, Trokhan S, DeRosa C, Chabot J.

J Surg Res. 1998 Dec;80(2):143-8.

PMID:
9878305
31.

A metastasizing model of anaplastic human Wilms tumor in the nude mouse.

Marvin MR, Kayton ML, O'Toole KM, Rowe DH, DeRosa C, Kindred A, Trokhan S, Chabot J, Kandel JJ.

Eur J Pediatr Surg. 1998 Oct;8(5):295-8.

PMID:
9825240
32.

Evidence of vascular growth associated with laser treatment of normal canine myocardium.

Kohmoto T, DeRosa CM, Yamamoto N, Fisher PE, Failey P, Smith CR, Burkhoff D.

Ann Thorac Surg. 1998 May;65(5):1360-7.

PMID:
9594867
33.

Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization.

Yamamoto N, Kohmoto T, Gu A, DeRosa C, Smith CR, Burkhoff D.

J Am Coll Cardiol. 1998 May;31(6):1426-33.

34.

The toxicologic hazard of superfund hazardous-waste sites.

Johnson BL, DeRosa C.

Rev Environ Health. 1997 Oct-Dec;12(4):235-51. Review.

PMID:
9553998
35.

Environmental exposures that affect the endocrine system: public health implications.

DeRosa C, Richter P, Pohl H, Jones DE.

J Toxicol Environ Health B Crit Rev. 1998 Jan-Mar;1(1):3-26. Review.

PMID:
9487091
36.

The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996.

Reiter LW, DeRosa C, Kavlock RJ, Lucier G, Mac MJ, Melillo J, Melnick RL, Sinks T, Walton BT.

Environ Health Perspect. 1998 Mar;106(3):105-13.

37.

Histologic analysis of transmyocardial channels: comparison of CO2 and holmium:YAG lasers.

Fisher PE, Khomoto T, DeRosa CM, Spotnitz HM, Smith CR, Burkhoff D.

Ann Thorac Surg. 1997 Aug;64(2):466-72.

PMID:
9262595
38.

Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.

Parham FM, Kohn MC, Matthews HB, DeRosa C, Portier CJ.

Toxicol Appl Pharmacol. 1997 Jun;144(2):340-7. Review.

PMID:
9194418
39.

Physiology, histology, and 2-week morphology of acute transmyocardial channels made with a CO2 laser.

Kohmoto T, Fisher PE, Gu A, Zhu SM, DeRosa CM, Smith CR, Burkhoff D.

Ann Thorac Surg. 1997 May;63(5):1275-83.

PMID:
9146314
40.

Assessment of transmyocardial perfusion in alligator hearts.

Kohmoto T, Argenziano M, Yamamoto N, Vliet KA, Gu A, DeRosa CM, Fisher PE, Spotnitz HM, Burkhoff D, Smith CR.

Circulation. 1997 Mar 18;95(6):1585-91.

PMID:
9118529
41.

Is aprotinin indicated for reoperative valvular surgery?

Goldstein DJ, DeRosa CM, Seldomridge JA, Weinberg AD, Oz MC, Smith CR.

J Heart Valve Dis. 1997 Jan;6(1):88-92.

PMID:
9044087
42.

Characterizing ventricular mechanics and energetics following repeated coronary microembolization.

Todaka K, Leibowitz D, Homma S, Fisher PE, Derosa C, Stennett R, Packer M, Burkhoff D.

Am J Physiol. 1997 Jan;272(1 Pt 2):H186-94.

PMID:
9038937
43.

ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem.

Mumtaz MM, George JD, Gold KW, Cibulas W, DeRosa CT.

Toxicol Ind Health. 1996 Nov-Dec;12(6):742-971. Review.

PMID:
9050165
44.

Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop.

Kavlock RJ, Daston GP, DeRosa C, Fenner-Crisp P, Gray LE, Kaattari S, Lucier G, Luster M, Mac MJ, Maczka C, Miller R, Moore J, Rolland R, Scott G, Sheehan DM, Sinks T, Tilson HA.

Environ Health Perspect. 1996 Aug;104 Suppl 4:715-40. Review.

45.

Strategic elements of ATSDR's Great Lakes Human Health Effects Research Program.

DeRosa CT, Johnson BL.

Toxicol Ind Health. 1996 May-Aug;12(3-4):315-25.

PMID:
8843549
46.

Histologic appearance of transmyocardial laser channels after 4 1/2 weeks.

Burkhoff D, Fisher PE, Apfelbaum M, Kohmoto T, DeRosa CM, Smith CR.

Ann Thorac Surg. 1996 May;61(5):1532-4; discussion 1534-5.

PMID:
8633979
47.

Health evaluation of 1,4-dioxane.

DeRosa CT, Wilbur S, Holler J, Richter P, Stevens YW.

Toxicol Ind Health. 1996 Jan-Feb;12(1):1-43. Review. No abstract available.

PMID:
8713712
48.

Chemical mixtures released from hazardous waste sites: implications for health risk assessment.

Johnson BL, DeRosa CT.

Toxicology. 1995 Dec 28;105(2-3):145-56.

PMID:
8571353
49.

Safety and efficacy of aprotinin under conditions of deep hypothermia and circulatory arrest.

Goldstein DJ, DeRosa CM, Mongero LB, Weinberg AD, Michler RE, Rose EA, Oz MC, Smith CR.

J Thorac Cardiovasc Surg. 1995 Dec;110(6):1615-21; discussion 1621-2.

50.

IFN-gamma and b7 as costimulators of antitumor immune-responses.

Flores I, Sarkar S, Derosa C, Ozzello L, Nabavi N, Shen Y, Ron Y, Pestka S.

Int J Oncol. 1995 Sep;7(3):501-9.

PMID:
21552866

Supplemental Content

Loading ...
Support Center